Delivery Order SPE2DB22D9207-SPE2DB25FH5CK
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,783.55 by the Defense Logistics Agency on July 25, 2025, for YF-VAX 1 dose vials. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a discrete procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,670.13 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order, which carries an ultimate completion date of August 25, 2025, was awarded without a set-aside designation. The delivery order represents a continuation of DMS Pharmaceutical Group's role as a critical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,701.30 by the Defense Logistics Agency on August 11, 2025, for the supply of YF-VAX 1 dose vials. This delivery order, with an ultimate completion date of September 2, 2025, carries no set-aside designation and will be performed at the contractor's facility in Park Ridge, Illinois. The award represents a discrete purchase...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,113.42 by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of YF-VAX 1 Dose Vials. The contract utilizes firm fixed-price pricing with an ultimate completion date of August 28, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 21, 2025, for the supply of YF-VAX 1 dose vials, with an ultimate completion date of August 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under DMS's existing $499.999 billion Indefinite Delivery Contract with DLA through the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,113.42 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of YF-VAX 1 Dose Vials. The contract carries no set-aside designation and specifies an ultimate completion date of August 15, 2025, with performance to take place at the awardee's Park Ridge location. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 25, 2025, for YF-VAX 1 dose vials with a ceiling value of $2,226.84. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 15, 2025, and will be performed at the vendor's Park Ridge location. The award falls under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,335.28 for YF-VAX 1 Dose Vials by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 7, 2025, represents a specific pharmaceutical product fulfillment under the company's existing contract vehicle. The award carries no...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $13,917.75 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 20, 2025, for YF-VAX 1 dose vials. The contract carries an ultimate completion date of September 11, 2025, and was awarded without set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,134.20 by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order is scheduled for completion by August 19, 2025, with performance taking place at the contractor's Park Ridge facility. The award was made without a set-aside designation, allowing DMS Pharmaceutical...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB25FH5CKDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of YF-VAX 1 Dose Vials. This delivery order, valued at $2,783.55 with an ultimate completion date of August 11, 2025, was issued without a set-aside designation. The contract represents a discrete delivery against DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. YF-VAX is a yellow fever vaccine used primarily for military personnel and Department of Defense beneficiaries requiring immunization protection. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established relationship with the DLA to deliver essential biologics and medical supplies to military health facilities. The firm's designation as a woman-owned small business has enabled it to compete effectively in federal procurement markets and establish itself as a key distributor of branded and generic medications, over-the-counter pharmaceuticals, and specialized medical consumables to government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/21/25 |